UBS Group’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $277K | Sell |
1,600
-149,600
| -99% | -$30.7M | ﹤0.01% | 6445 |
|
|
2025
Q4 | $38.7M | Sell |
151,200
-39,200
| -21% | -$10.3M | 0.01% | 1896 |
|
|
2025
Q3 | $49.5M | Buy |
190,400
+109,300
| +135% | +$28.7M | 0.01% | 1629 |
|
|
2025
Q2 | $19.8M | Sell |
81,100
-60,700
| -43% | -$15.1M | ﹤0.01% | 2366 |
|
|
2025
Q1 | $37.5M | Sell |
141,800
-99,400
| -41% | -$26.9M | 0.01% | 1733 |
|
|
2024
Q4 | $61.2M | Buy |
241,200
+110,400
| +84% | +$29.6M | 0.01% | 1280 |
|
|
2024
Q3 | $41.4M | Sell |
130,800
-47,200
| -27% | -$16.8M | 0.01% | 1284 |
|
|
2024
Q2 | $66.5M | Buy |
178,000
+75,100
| +73% | +$25.4M | 0.02% | 854 |
|
|
2024
Q1 | $35.7M | Sell |
102,900
-105,500
| -51% | -$40M | 0.01% | 1268 |
|
|
2023
Q4 | $95.4M | Buy |
208,400
+44,000
| +27% | +$21.7M | 0.03% | 588 |
|
|
2023
Q3 | $80M | Buy |
164,400
+21,000
| +15% | +$9.87M | 0.03% | 593 |
|
|
2023
Q2 | $64.1M | Sell |
143,400
-30,500
| -18% | -$15.4M | 0.02% | 695 |
|
|
2023
Q1 | $84.4M | Buy |
173,900
+32,900
| +23% | +$16.3M | 0.03% | 524 |
|
|
2022
Q4 | $72.2M | Buy |
141,000
+72,600
| +106% | +$38.2M | 0.03% | 621 |
|
|
2022
Q3 | $33.2M | Buy |
68,400
+6,100
| +10% | +$2.97M | 0.01% | 940 |
|
|
2022
Q2 | $29.2M | Buy |
62,300
+25,300
| +68% | +$11.3M | 0.01% | 1077 |
|
|
2022
Q1 | $16.1M | Hold |
37,000
| – | – | 0.01% | 1605 |
|
|
2021
Q4 | $17.2M | Buy |
+37,000
| New | +$16.4M | ﹤0.01% | 1688 |
|
|
2021
Q1 | – | Sell |
-1,500
| Closed | -$615K | – | 9201 |
|
|
2020
Q4 | $615K | Buy |
+1,500
| New | +$624K | ﹤0.01% | 4434 |
|
|
2020
Q3 | – | Sell |
-3,000
| Closed | -$1.16M | – | 8178 |
|
|
2020
Q2 | $1.16M | Buy |
+3,000
| New | +$1.12M | ﹤0.01% | 3378 |
|
|
2020
Q1 | – | Sell |
-31,200
| Closed | -$11.4M | – | 8145 |
|
|
2019
Q4 | $11.4M | Buy |
31,200
+27,500
| +743% | +$8.72M | ﹤0.01% | 1834 |
|
|
2019
Q3 | $946K | Sell |
3,700
-300
| -8% | -$84.1K | ﹤0.01% | 4012 |
|
|
2019
Q2 | $1.06M | Hold |
4,000
| – | – | ﹤0.01% | 3717 |
|
|
2019
Q1 | $1.06M | Buy |
+4,000
| New | +$1.15M | ﹤0.01% | 3534 |
|
|
2018
Q4 | – | Sell |
-16,800
| Closed | -$5.69M | – | 8141 |
|
|
2018
Q3 | $5.69M | Buy |
16,800
+12,900
| +331% | +$4.19M | ﹤0.01% | 2241 |
|
|
2018
Q2 | $1.16M | Sell |
3,900
-146,700
| -97% | -$43M | ﹤0.01% | 3645 |
|
|
2018
Q1 | $40.5M | Buy |
150,600
+147,900
| +5,478% | +$40M | 0.02% | 737 |
|
|
2017
Q4 | $670K | Buy |
2,700
+800
| +42% | +$198K | ﹤0.01% | 4084 |
|
|
2017
Q3 | $463K | Buy |
+1,900
| New | +$466K | ﹤0.01% | 4267 |
|
|
2017
Q1 | – | Sell |
-223,600
| Closed | -$45.6M | – | 7776 |
|
|
2016
Q4 | $45.6M | Buy |
223,600
+85,400
| +62% | +$16.3M | 0.03% | 590 |
|
|
2016
Q3 | $24.4M | Buy |
+138,200
| New | +$24M | 0.01% | 856 |
|
|
2016
Q1 | – | Sell |
-9,300
| Closed | -$1.66M | – | 7860 |
|
|
2015
Q4 | $1.66M | Buy |
+9,300
| New | +$1.63M | ﹤0.01% | 2973 |
|
|
2015
Q3 | – | Sell |
-33,800
| Closed | -$6.46M | – | 8503 |
|
|
2015
Q2 | $6.46M | Buy |
33,800
+20,300
| +150% | +$3.77M | ﹤0.01% | 1835 |
|
|
2015
Q1 | $2.4M | Buy |
13,500
+12,600
| +1,400% | +$1.99M | ﹤0.01% | 2768 |
|
|
2014
Q4 | $129K | Buy |
+900
| New | +$123K | ﹤0.01% | 5452 |
|
Other funds holding HUM
VCM
VPM
SC
UBS Group's HUM Position: Q1 2026 in Review
UBS Group reduced its Humana (HUM) stake by 28% in Q1 2026, selling an estimated $33.4M and leaving 415,336 shares worth $72M. The position accounts for 0.01% of the portfolio, ranked #1296.
UBS Group first reported a position in HUM in Q4 2014 and has held it in 46 quarters since. The position peaked at $188M in Q4 2017. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.
- UBS Group held 415,336 shares of Humana worth $72M as of Q1 2026.
- UBS Group sold 163,055 Humana shares in Q1 2026, an estimated $33.4M.
- Humana made up 0.01% of UBS Group's portfolio in Q1 2026, its #1296 holding.
- UBS Group first reported a position in Humana in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Humana position peaked at $188M in Q4 2017.
- 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.